美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,470.19

+6.990.48%

涨家数：16

跌家数：4

平家数：- -

市盈率：- -

高：1,477.47

开：1,463.87

低：1,459.06

收：1,463.19

数据加载中...

总览新闻资讯

第一三共/阿斯利康(AZN.US)重磅抗体偶联药物(ADC)Enhertu在3期临床试验中获得积极结果

BUZZ-Moderna 在首席执行官 Stephane Bancel 购买股票后上涨

阿斯利康中国总经理林骁带队参访上药云健康“益药综合旗舰体”，共筑医药创新服务新生态

自家CEO大举增持！Moderna将是“AI+医疗”投资浪潮的下一个爆点？

Vir Biotechnology, Inc.盘中异动下午盘快速上涨5.04%

伊诺维奥制药盘中异动急速拉升5.43%

雷克兰医疗工业盘中异动股价大跌5.58%

阿斯利康(AZN)盘前升1.52% 重度哮喘治疗药物显示积极效果

阿斯利康全球研发（中国）有限公司药品申请临床试验默示许可获受理

Coinbase Coin50指数新增PEPE、WIF、COMP、APT、AERO

辉瑞天价并购获得的产品，如今是赚还是亏？

Insight数据库

Equillium, Inc.盘中异动股价大跌5.73%

诺瓦瓦克斯医药盘中异动下午盘快速跳水5.04%

Aethlon Medical, Inc.盘中异动快速下跌8.83%

伊诺维奥制药盘中异动大幅下跌5.30%报1.88美元

Vir Biotechnology, Inc.盘中异动股价大跌5.01%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1470.1858,"timestamp":1741208399999,"preClose":1463.1935,"halted":0,"volume":109592550,"delay":0,"changeRate":0.004779,"change":6.99231,"pbRate":4.026038,"amount":6617899521.798556,"amplitude":0.012581,"prevYearClose":1274.8187,"fiveDayClose":1446.2988,"twentyDayClose":1349.0913,"turnoverRate":0.007086,"marketCap":1213413587744,"floatMarketCap":1190674811824.5,"peRate":31.895692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1477.4664,"amplitude":0.012581,"preClose":1463.1935,"low":1459.0585,"pbRate":"4.026038","latestPrice":1470.1858,"volume":109592550,"delay":0,"open":1463.8671,"prevYearClose":1274.8187,"prevWeekClose":1463.5875,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1446.2988,"twentyDayClose":1349.0913,"sixtyDayClose":1293.0415,"secType":"PLATE","market":"US","turnoverRate":0.007086,"peRate":31.895692,"marketCap":1213413587744,"floatMarketCap":1190674811824.5,"timestamp":1741208399999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":16,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517111989","title":"第一三共/阿斯利康(AZN.US)重磅抗体偶联药物(ADC)Enhertu在3期临床试验中获得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2517111989","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517111989?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 21:15","pubTimestamp":1741180517,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，阿斯利康和第一三共公司日前宣布，双方联合开发的重磅抗体偶联药物Enhertu，在3期临床试验DESTINY-Gastric04中获得积极结果。新闻稿表示，Enhertu是首个在随机3期临床试验中，作为二线疗法显著改善HER2阳性胃癌患者总生存期的HER2靶向疗法。新闻稿指出，转移性HER2阳性胃癌一线治疗出现疾病进展后，历史上在随机临床试验中，尚未有HER2靶向药物在二线治疗中展示出生存获益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0320765992.SGD","LU2456880835.USD","BK1576","BK4231","LU0109394709.USD","LU1829250122.USD","LU2417539215.USD","BK4588","ADC","BK4080","LU2462157665.USD","BK1583","BK1141","AZN","BK4568","BK4007","LU2236285917.USD","03347","LU0889565916.HKD","BK4585"],"gpt_icon":0},{"id":"2517916120","title":"BUZZ-Moderna 在首席执行官 Stephane Bancel 购买股票后上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916120","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916120?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 20:42","pubTimestamp":1741178524,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna 在首席执行官 Stephane Bancel 购买股票后上涨3月5日 -  ** 疫苗制造商 Moderna MRNA.O 股价盘前上涨 9.2% 至 33.19 美元 ** 美国证券交易委员会周二晚些时候的文件显示，公司首席执行官Stephane Bancel以每股约31美元的价格买入了约16万股MRNA股票。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3S3PO15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4533","BK4534","BK4501","BK4532","BK4588","BK4548","BK4139","MRNA","BK4585","BK4568"],"gpt_icon":0},{"id":"2517950057","title":"阿斯利康中国总经理林骁带队参访上药云健康“益药 综合旗舰体”，共筑医药创新服务新生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2517950057","media":"上海医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517950057?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 12:37","pubTimestamp":1741149420,"startTime":"0","endTime":"0","summary":"双方深入探讨中国医药零售创新业务、患者服务、创新支付及市场拓展等方面业务合作机遇。林骁阿斯利康中国总经理　　“益药·综合旗舰体”的创新模式和服务理念给林骁留下了深刻印象，同时，他对上药控股“服务为荣”的企业文化给予了高度评价。林骁表示，作为阿斯利康重要的战略合作伙伴，十分感谢上海医药多年来的大力支持。　　林骁强调，阿斯利康对“健康中国2030”战略目标的承诺坚定不移。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-05/doc-inenqpam9007583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2236285917.USD","AZN","LU1829250122.USD","BK4588","09939","LU2456880835.USD","LU0109394709.USD","BK1515","BK4007","BK1574","BK4585","LU0889565916.HKD","LU2417539215.USD","LU2462157665.USD","BK4568","BK1161","159938","LU0320765992.SGD"],"gpt_icon":0},{"id":"2517955650","title":"自家CEO大举增持！Moderna将是“AI+医疗”投资浪潮的下一个爆点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2517955650","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517955650?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 11:33","pubTimestamp":1741145592,"startTime":"0","endTime":"0","summary":"此次增持之后后，波士顿生物科技风投公司持有高达660万股Moderna股票。“国会山股神”佩洛西凭一己之力带火Tempus AI对于看好Moderna股价前景的投资者们来说，自家公司CEO大举增持无疑将大幅提振市场信心，更重要的是，有投资机构将CEO增持行动视为Moderna管理层看好该公司将在“AI+医疗”超级大浪潮中将处于非常有利的地位。市场看好Moderna成为“AI+医疗”爆发标的的逻辑与高盛看好雅培的逻辑基本一致。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257863.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"自家CEO大举增持！Moderna将是“AI+医疗”投资浪潮的下一个爆点？","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4534","BK4533","BK4568","BK4585","BK4588","BK4548","BK4551","BK4532","BK4501"],"gpt_icon":1},{"id":"2517348985","title":"Vir Biotechnology, Inc.盘中异动 下午盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517348985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517348985?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 04:23","pubTimestamp":1741119820,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时23分，Vir Biotechnology, Inc.股票出现波动，股价大幅拉升5.04%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042340a25f66de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042340a25f66de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","VIR","BK4535","BK4568","BK4139"],"gpt_icon":0},{"id":"2517985310","title":"伊诺维奥制药盘中异动 急速拉升5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517985310?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 04:20","pubTimestamp":1741119617,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时20分，伊诺维奥制药股票出现波动，股价急速拉升5.43%。截至发稿，该股报1.94美元/股，成交量49.8997万股，换手率1.38%，振幅7.07%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.13%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042017abe85268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042017abe85268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4583","BK4139","INO"],"gpt_icon":0},{"id":"2516677596","title":"雷克兰医疗工业盘中异动 股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516677596?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 22:44","pubTimestamp":1741099487,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时44分，雷克兰医疗工业股票出现波动，股价快速下跌5.58%。截至发稿，该股报21.84美元/股，成交量9858股，换手率0.10%，振幅4.63%。雷克兰医疗工业股票所在的服装制造行业中，整体跌幅为1.87%。其相关个股中，Figs, Inc.、Perfect Moment Ltd.、兰亭集势涨幅较大，儿童之家、金铉集团、思宏国际较为活跃，换手率分别为0.62%、0.41%、0.22%，振幅较大的相关个股有即亮集团、雷克兰医疗工业、儿童之家，振幅分别为5.34%、4.63%、4.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224447abe7f3fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224447abe7f3fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LAKE","BK4568","IE00B66KJ199.SGD","IE0031619046.USD","IE00B7SZL793.SGD","BK4202","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2516626829","title":"阿斯利康(AZN)盘前升1.52% 重度哮喘治疗药物显示积极效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2516626829","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516626829?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 17:59","pubTimestamp":1741082382,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿斯利康(AZN)盘前股价走高，暂升1.52%，报77.26美元。消息面上，在近期于美国加州圣地亚哥举办的美国过敏、哮喘和免疫学会年会（AAAAI）上，阿斯利康一款用于重度哮喘治疗的药物特泽利尤单抗（Tezepelumab），在慢性鼻窦炎伴鼻息肉的治疗领域呈现出令人瞩目的积极效果。依据一项三期临床研究成果，特泽利尤单抗能够显著缓解慢性鼻窦炎伴鼻息肉患者的鼻塞症状，有效缩小息肉体积，近乎让患者无需进行手术治疗。这一最新研究数据已发表于《新英格兰医学杂志》，并以最新突破性研究口头报告的形式，在 2025 年 AAAAI 大会上予以发布。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"286019","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0320765992.SGD","LU2456880835.USD","BK4007","BK4585","LU2462157665.USD","LU1829250122.USD","LU2236285917.USD","BK4588","LU0889565916.HKD","BK4568","LU2417539215.USD","AZN"],"gpt_icon":0},{"id":"2516661606","title":"阿斯利康全球研发（中国）有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2516661606","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516661606?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 12:18","pubTimestamp":1741061880,"startTime":"0","endTime":"0","summary":"3月4日，据CDE官网消息，阿斯利康全球研发（中国）有限公司、阿斯利康制药有限公司、上海合全医药有限公司联合申请药品“Ceralasertib薄膜包衣片”，获得临床试验默示许可，受理号CXHB2400299。阿斯利康全球研发（中国）有限公司，成立于2021年，位于上海市，是一家以从事研究和试验发展为主的企业。主要股东信息显示，阿斯利康全球研发（中国）有限公司由阿斯利康大陆有限公司 ASTRAZENECA CONTINENT B.V.持股100%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/04121848504570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2456880835.USD","BK4588","BK4585","AZN","LU0320765992.SGD","LU2417539215.USD","BK1583","BK4568","LU2462157665.USD","BK1576","BK4007","LU0889565916.HKD","BK1141","03347","LU2236285917.USD","LU1829250122.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2516696867","title":"Coinbase Coin50指数新增PEPE、WIF、COMP、APT、AERO","url":"https://stock-news.laohu8.com/highlight/detail?id=2516696867","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516696867?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 09:01","pubTimestamp":1741050074,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/coinbasetraders/status/1896696391336149118?s=46&t=bcMyidYO0QkS5ajIW9CBdg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4079","BK4535","LU1861559042.SGD","BK6088","BLZ.SI","BK4595","BK4539","APT.USD.HKCC","COMP","BK6522","BK4112","LU1861558580.USD","BK4516","BK4596","BK4588","COIN","BK4585","BK4568","COMP.USD.CC","COMP.USD.HKCC","BK4551","BK4086","BK4554","APT.USD.CC","BK4600","APT"],"gpt_icon":0},{"id":"2516612755","title":"辉瑞天价并购获得的产品，如今是赚还是亏？","url":"https://stock-news.laohu8.com/highlight/detail?id=2516612755","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516612755?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 08:03","pubTimestamp":1741046636,"startTime":"0","endTime":"0","summary":"获得的管线中，哪些成了辉瑞新的增长动力？辉瑞需要通过伊曲莫德未来的表现，来体现这次收购的价值。当时已经上市的沃塞洛托，因为最新临床数据中，出现了高于预期的死亡率事件，如今已经撤市。总的来说，辉瑞通过收购成熟产品，快速补强了管线，尤其在肿瘤、偏头痛领域，都已经兑现了价值，但自免领域和血液罕见病领域，目前还处于消化期，未来给辉瑞带来多少销售增量，还需要时间来验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304135745abe74147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304135745abe74147&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","SG9999003800.SGD","BK4581","LU1894683348.USD","BK4588","LU0225771236.USD","BK4533","LU0868494617.USD","SG9999013999.USD","LU0058720904.USD","LU1894683264.USD","SG9999001176.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU0321505439.SGD","LU0289739699.SGD","SG9999001176.SGD","BK4007","IE00B19Z3B42.SGD","IE0002270589.USD","LU0321505868.SGD","LU1066053197.SGD","IE00B19Z3581.USD","BK4568","BK4534","LU0306807586.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU1883839398.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0122379950.USD","BK4592","SGXZ57979304.SGD","LU1057294990.SGD","BK4599","LU0985481810.HKD","LU0306806265.USD","PFE","IE000M9KFDE8.USD","LU0456855351.SGD","LU1066051498.USD","SG9999002232.USD","SG9999011175.SGD","IE00BBT3K403.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2516663928","title":"Equillium, Inc.盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516663928?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 04:37","pubTimestamp":1741034264,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时37分，Equillium, Inc.股票出现波动，股价大幅下挫5.73%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Celularity Inc C/Wts 16/07/2026 涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为215.52%、187.68%、163.60%，振幅较大的相关个股有Radiopharm Theranostics Limited、Entero Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为119.50%、70.53%、64.88%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040437449637fdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040437449637fdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2516266817","title":"诺瓦瓦克斯医药盘中异动 下午盘快速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516266817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516266817?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 04:12","pubTimestamp":1741032743,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时12分，诺瓦瓦克斯医药股票出现波动，股价快速下挫5.04%。截至发稿，该股报7.91美元/股，成交量441.937万股，换手率2.75%，振幅8.64%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.06%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041223989a5b82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041223989a5b82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","NVAX","BK4139","BK4547","BK4585","BK4588"],"gpt_icon":0},{"id":"2516965074","title":"Aethlon Medical, Inc.盘中异动 快速下跌8.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516965074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516965074?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 03:52","pubTimestamp":1741031535,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时52分，Aethlon Medical, Inc.股票出现异动，股价急速下挫8.83%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体涨幅为1.08%。其相关个股中，Adagio Medical Holdings, Inc、Senseonics Holdings, Inc.、Lensar, Inc.涨幅较大，Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为49.16%、17.71%、12.29%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ，振幅分别为71.96%、59.09%、40.86%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304035215abe68bf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304035215abe68bf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4583","AEMD","BK4568"],"gpt_icon":0},{"id":"2516124657","title":"伊诺维奥制药盘中异动 大幅下跌5.30%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516124657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516124657?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 03:18","pubTimestamp":1741029490,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时18分，伊诺维奥制药股票出现异动，股价快速下跌5.30%。截至发稿，该股报1.88美元/股，成交量40.3712万股，换手率1.12%，振幅5.81%。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.37%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304031811989a4ef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304031811989a4ef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4568","BK4583","BK4139"],"gpt_icon":0},{"id":"2516077652","title":"Vir Biotechnology, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516077652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516077652?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 02:52","pubTimestamp":1741027951,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时52分，Vir Biotechnology, Inc.股票出现异动，股价急速下挫5.01%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4444.65%、200.45%、179.81%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025231abe67d4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025231abe67d4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4535","BK4139","VIR","BK4568"],"gpt_icon":0}],"pageSize":16,"totalPage":10,"pageCount":2,"totalSize":156}]}}